HAP Trading’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-22,500
Closed -$27K 1191
2017
Q2
$27K Buy
+22,500
New +$645K ﹤0.01% 759

Other funds holding LJPC

HAP Trading's LJPC Position: Q2 2018 in Review

HAP Trading sold out of La Jolla Pharmaceutical Company (LJPC) in Q2 2018, closing a stake of 36,636 shares — an estimated $1.09M sold.

HAP Trading first reported a position in LJPC in Q3 2017 and held it in 2 quarters. The position peaked at $2.62M in Q3 2017. 95 funds tracked by Wall St. Rank hold LJPC as of Q2 2018.

  • HAP Trading reported no remaining La Jolla Pharmaceutical Company position as of Q2 2018 after selling out during the quarter.
  • HAP Trading sold 36,636 La Jolla Pharmaceutical Company shares in Q2 2018, an estimated $1.09M.
  • HAP Trading first reported a position in La Jolla Pharmaceutical Company in Q3 2017 and held it in 2 quarters.
  • HAP Trading's La Jolla Pharmaceutical Company position peaked at $2.62M in Q3 2017.
  • 95 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q2 2018.

Based on HAP Trading's 13F filing for Q2 2018, filed 13 Aug 2018.